Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyxeos vs 7+3 in Elderly High-Risk AML
NCT01696084Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cytarabine in acute myeloid leukemia (AML), sponsored by Jazz Pharmaceuticals plc. Started Dec 2012; status: completed.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01696084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696084.